SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-015991
Filing Date
2024-06-07
Accepted
2024-06-07 16:32:41
Documents
2
Period of Report
2024-06-05

Document Format Files

Seq Description Document Type Size
1 form4-06072024_080638.html 4  
1 form4-06072024_080638.xml 4 4053
2 ex24-06072024_080649.htm EX-24 7017
  Complete submission text file 0001415889-24-015991.txt   12554
Mailing Address 230 PARK AVENUE, SUITE 2800 NEW YORK NY 10169
Business Address
Harrison Seth Loring (Reporting) CIK: 0001404955 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38938 | Film No.: 241030105

Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Issuer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)